Sun Life is named a strategic Workday Wellness partner to make benefits easier for employers through enhanced data connectivity
"Our goal is to make using our benefits – whether you're the employer or the employee – as simple as possible, while delivering the most value," said Joi Tillman, president, Group Benefits, Sun Life U.S. "As a Workday Wellness partner, we will be able to enhance the benefits experience for everyone by creating a more seamless experience, and enabling better access to benefits and health services."
A long-standing Workday partner, Sun Life has developed a broad portfolio of data connection solutions (application programming interfaces or APIs), known as Sun Life Link, which automate benefit data exchanges to and from Sun Life employer clients through the Workday platform. The automation of these tasks gives substantial time back to HR teams so they can focus on the projects and aspects of their job that really matter to them, like engaging with and caring for employees.
As a Workday Wellness partner, Sun Life is developing additional APIs that enhance connectivity for employers by integrating more employee data for functions like plan setup, enrollment and eligibility, absence management, EOI (evidence of insurability) and billing. By aligning benefits and wellness program data with other employee data, employees can spend less time managing their benefits, and more time experiencing the support services and health access programs their benefits provide.
For more information on Sun Life's work as a Workday Wellness partner, visit: https://sunlife.com/workday-wellness.
About Sun LifeSun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of December 31, 2024, Sun Life had total assets under management of C$1.54 trillion. For more information, please visit www.sunlife.com.
Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.
Sun Life U.S. is one of the largest providers of employee and government benefits, helping approximately 50 million Americans access the care and coverage they need. Through employers, industry partners and government programs, Sun Life U.S. offers a portfolio of benefits and services, including dental, vision, disability, absence management, life, supplemental health, medical stop-loss insurance, and healthcare navigation. Sun Life employs more than 8,500 people in the U.S., including associates in our partner dental practices and affiliated companies in asset management. Group insurance policies are issued by Sun Life Assurance Company of Canada (Wellesley Hills, Mass.), except in New York, where policies are issued by Sun Life and Health Insurance Company (U.S.) (Lansing, Mich.). For more information visit our website and newsroom.
Media contacts
Devon FernaldSun Life U.S.Devon.Portney.Fernald@sunlife.com781-800-3609
Connect with Sun Life U.S.
https://www.facebook.com/SLFUnitedStates https://www.linkedin.com/company/sun-life-financial https://twitter.com/SunLifeUS
View original content to download multimedia:https://www.prnewswire.com/news-releases/sun-life-is-named-a-strategic-workday-wellness-partner-to-make-benefits-easier-for-employers-through-enhanced-data-connectivity-302393640.html
SOURCE Sun Life U.S.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
10 minutes ago
Moving to a walkable city can add more than 1,000 steps to your day: Study
People who moved to cities with better walkability logged about 1,100 more steps per day and were nearly twice as likely to meet exercise goals, according to a large U.S. relocation study published in the journal Nature on Wednesday. Researchers from the University of Washington and Stanford University tracked about 5,500 Americans of all ages and fitness levels as they moved between 1,600 U.S. cities, monitoring their activity for 90 days before and after the move, from 2013 to 2016. Using smartphone step counts and the Walk Score system, which rates locations from 0 to 100 based on access to amenities like stores, parks and schools, they found that moving from a low-walkability city (48 or less) to a high-walkability one (75 or more) added an average of 1,100 steps a day. That equated to roughly 11 extra minutes of walking per day, or about one additional hour of moderate-to-vigorous physical activity per week. The biggest jump came from moves to places like New York City, where a Walk Score of 89 translated to daily steps climbing from about 5,600 to 7,000. "We were positively surprised by the size of that effect," Tim Althoff, the lead author of the study and an associate professor at the University of Washington in the Paul G. Allen School of Computer Science & Engineering, said. "On average, people walked about 1,400 steps every day more when they moved to New York, or if they moved [in] the opposite direction, they lost about 1,400 steps a day." However, Althoff noted that not all steps are created equal. "Most of the difference actually was in this kind of brisk walk regime that is considered moderate or above," he said. In those who moved from low- to high-walkability cities, the proportion who met the U.S. physical activity guidelines increased from 21.5% before relocation to 42.5% after relocation. Many also moved closer to the CDC's recommended 150 minutes of moderate intensity physical activity a week or roughly 8,000 steps of brisk walking. If all U.S. cities matched Chicago's or Philadelphia's walkability (Walk Score 78), 36 million more Americans could meet national activity targets, a simulation performed as part of the study found. If cities matched New York City's walkability (89), that number could rise to 47 million. One group, however, did not see a step-count bump: women over 50. The researchers suggested this could stem from safety concerns, caregiving responsibilities and poor transit access. "Improving the built environment is a great start, but it's not kind of this one size fits all improvement that benefits absolutely everybody," Althoff said. "It still needs to be paired with targeted health intervention." In the U.S., more than 8% of all deaths are linked to insufficient physical activity, which is associated with about $117 billion in annual healthcare costs, according to the CDC. "Physical inactivity is the fourth underlying cause of death in the world and in the country because it contributes to so many chronic diseases as well as infectious diseases and mental health conditions," James Sallis, distinguished professor emeritus at the School of Public Health, University of California at San Diego, said. Sallis stressed that walkability is about giving people safe ways to reach their destinations without relying on a car. "Hopefully a study this large and this impressive will help convince city leaders that not making good conditions for walking is really doing a disservice to the residents," he said. The study's findings highlight the ways in which urban design can significantly influence physical activity and population health, according to Althoff. "Helping city planners and policymakers know exactly where to direct resources and for the best results of the health of large populations in the cities is a key part," he said.
Chicago Tribune
39 minutes ago
- Chicago Tribune
The silent disease that's been killing Americans for decades — And what doctors are doing about it
Heart disease remains the leading cause of death in the U.S., claiming a life every 34 seconds. But beyond heart attacks or other sudden events, a quieter threat is building inside Americans' blood vessels. It's called arterial calcification, an often overlooked driver of serious health complications. Now a breakthrough technology offers hope for better treatment. When arteries become narrowed or hardened due to the buildup of plaque, it's known as atherosclerosis. Over time, these plaques can calcify, meaning they harden into rigid, rocklike deposits that line the inner or middle walls of arteries. This process, called calcification, makes arteries less flexible and more likely to get blocked, raising the risk of heart attacks, strokes and limb loss. Peripheral artery disease is a common result of this process. It happens when narrowed or hardened arteries reduce blood flow to the legs and feet. PAD affects approximately 230 million people worldwide, yet many don't realize it. Arterial calcification can also affect the arteries that supply the heart, leading to coronary artery disease. When blood flow to the heart is restricted, it can cause chest pain, shortness of breath and heart attacks. Annually, the disease results in 17.8 million deaths worldwide. Like PAD, CAD develops silently over time. Once identified, calcified plaques are notoriously hard to treat. Standard procedures can work well for soft plaque. Doctors thread a tiny balloon into the blocked artery, inflate it to compress the blockage, then often insert a metal mesh tube called a stent to keep the vessel open. With calcified arteries, rigid calcium often doesn't budge. Traditional balloons may fail to expand or cause artery tears. Similarly, stents may not fully deploy, increasing procedural complications. In short, older tools try to push through the problem. But next-generation technology uses a different approach: preparing the artery first, helping ensure procedures are safer and more efficient. Enter intravascular lithotripsy, a breakthrough therapy that borrows from an unexpected source: kidney stone treatment. For decades, doctors have used sound waves to break up kidney stones through a minimally invasive procedure. IVL applies the same principle inside the artery, delivering controlled sonic pulses through a modified balloon catheter to gently crack calcium deposits from within. This approach avoids many complications of more aggressive procedures and is considered one of the most promising developments in interventional cardiology. IVL was first approved for coronary use just four years ago, with adoption growing rapidly. One early IVL company quickly became the market leader and was acquired by Johnson & Johnson in 2024 — another sign of the technology's growing importance in cardiovascular Medical is a standout innovator in the IVL space, pushing the boundaries of energy delivery and procedural efficiency to elevate outcomes in peripheral and coronary interventions. 'FastWave Medical's novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse,' says Dr. Kathleen Kearney, medical director of the Cardiac Cath Lab at UWMC Montlake. 'These technological improvements are greatly needed to empower physicians in providing more effective treatment to their patients.' But what makes FastWave particularly noteworthy isn't just its technology; it's who's backing it. Alongside venture investors, physicians — cardiologists, vascular surgeons and interventional radiologists — have invested in the company. Their involvement signals more than financial interest; it reflects confidence in the system's potential to address the daily challenges they face in the cath lab. When physicians invest in medical technology, it demonstrates something powerful: They believe it will genuinely improve their ability to deliver high-quality care. 'FastWave is moving quickly and decisively to become best-in-class in the IVL space,' said Dr. Arthur Lee, director of peripheral vascular services at the Cardiac and Vascular Institute. 'We are excited to support the development of this groundbreaking technology and get it into the hands of those who need it most.' 'Calcified arteries remain one of the most difficult conditions to treat in our field,' added Dr. Amir Kaki, director of mechanical circulatory support and high-risk coronary interventions at Henry Ford St. John Hospital. 'FastWave's IVL platform is a compelling advancement that should provide a more precise, efficient and predictable way to manage complex arterial disease.' As of July 2025, the company holds a total of eight patents, with several more applications underway. These patents span key areas of the technology from energy delivery to catheter design. Early study results are encouraging for the company's dual IVL platforms. In June, FastWave successfully completed initial first-in-human procedures as part of an ongoing feasibility study for its coronary laser-based IVL system. An Investigational Device Exemption is also planned to evaluate its electric IVL system for the treatment of PAD. 'Calcified lesions aren't just a technical challenge — the condition remains one of the most significant barriers to successful peripheral interventions,' said Dr. Sahil Parikh, director of endovascular services at Columbia University Irving Medical Center. 'FastWave's upcoming IDE trial for PAD will give us a chance to assess whether an advanced IVL system can meaningfully improve the lives of patients who suffer from this difficult disease.' Dr. Venita Chandra, clinical professor of surgery at Stanford Health Care, expects the trial to reveal whether FastWave's device will offer doctors a better tool for difficult cases. 'The key question isn't just whether a device works but whether it makes procedures more efficient and provides physicians with a more predictable tool for treating patients with complex arterial disease,' she said. The stakes are rising rapidly. As the population ages and rates of diabetes and obesity continue to climb, more patients will face PAD and CAD. For the most difficult cases, treatment options are quite limited. But innovation is catching up. First-generation IVL introduced a new treatment paradigm; now advanced tools from startups like FastWave promise doctors more ways to treat this disease.
Business Insider
40 minutes ago
- Business Insider
Mark Cuban says companies should be taxed more for buying back their own shares
In an X post on Tuesday, the billionaire investor said raising the federal tax on the practice would push companies to reinvest in their businesses and hit wealthy shareholders — including himself — the hardest. The "Shark Tank" star called it "a way to charge the biggest public companies more" while shifting incentives toward long-term growth. Stock buybacks, also called share repurchases, happen when a company buys back its stock from investors, often reducing the number of shares in circulation. This can boost earnings per share and, in turn, the stock price, benefiting remaining shareholders. Critics say the practice can prioritize short-term gains over long-term investment. American companies bought back $166 billion in shares in July — the highest July total on record — bringing the year-to-date tally to $926 billion, surpassing the previous year-to-date record set in 2022 by $108 billion, per data from stock market research firm Birinyi Associates. The US has had a 1% tax on stock repurchases on publicly traded corporations since the Inflation Reduction Act, which took effect on January 1, 2023. Cuban said that a higher tax could encourage firms to use the cash to expand or pay dividends to shareholders, which he said would be tax-free for many Americans. "Married households making under 94k pay no taxes on it," Cuban wrote. "If I own it. I pay full taxes." In a follow-up X post, Cuban suggested exempting companies from the higher tax if they distributed repurchased shares to all employees, from interns to the CEO, based on each worker's share of total annual cash earnings. He said this would be a "baby step" toward reducing income inequality and boosting workers' net worth. A market correction could encourage more buybacks Citi predicted in a March note that there would be $1 trillion in buybacks for the year, up 11% from about $900 billion in 2024. The bank said market declines could spur more repurchases, as companies seize the chance to buy their shares at discounted levels. Citi said large firms like Apple, Alphabet, Nvidia, Wells Fargo, and Visa repurchased roughly $190 billion in stock last year alone. Citi's forecast came before a series of market warnings from Wall Street strategists. Analysts at BTIG, Evercore ISI, Stifel, Morgan Stanley, and Wells Fargo have all flagged the potential for a correction in the S&P 500 in the coming months. They cited stretched valuations, seasonal weakness in August and September, and uncertainty over tariffs' economic impact.
